News by Subject Medicine & Health

Mass General Hospital recently performed the largest number of adult heart transplants in the country using what are known as Donation after Circulatory Death (DCD) donor hearts.

Scientists have developed a new way to understand complex genetic diseases and have identified a gene that modifies the severity of inherited kidney disease, paving the way for personalized treatments.

A new study provides hope that the number of children dying on the transplantation list while waiting for a new heart could potentially be reduced dramatically. The study, published online in the Annals of Thoracic Surgery, demonstrates that many of the donor hearts deemed 'high-risk' can be transplanted with the same survival rates as 'low-risk' donor hearts.

A recently published study indicates that oral infections seem to have no association with the risk of stem cell transplantation patients dying of or getting a serious infection within six months of the procedure.

Patients who were transplanted with hearts from hepatitis C-positive donors had comparable outcomes after one year to patients who received hearts from donors that didn't have the disease, according to a Vanderbilt University Medical Center study published in JAMA Cardiology.

Researchers at Vanderbilt University Medical Center in Nashville, Tenn., report in this case series on 80 patients who had heart transplants using hearts from donors positive for hepatitis C.